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Abstract
Background and purpose: Preoperative irradiation with direct postoperative chemotherapy could benefit patients undergoing surgery for 
colorectal cancer. This study was designed to examine, in an experimental model, if such treatment is feasible without detrimental effects 
on early anastomotic healing.
Material and methods: A colonic segment was irradiated (25 Gy) in 3 groups (n= 10 each) of male Wistar rats. After 5 days, a colonic 
resection was performed with anastomotic construction; only the distal limb consisted of irradiated bowel. Postoperatively, animals 
received daily intraperitoneal 5-fluorouracil (5-FU, group I/CH: 17.5 mg/kg; group I/CL: 12.5 mg/kg) or saline (group I). Three 
additional groups were treated similarly, but with sham-irradiation: CH, CL and C, respectively. A ll rats were killed 7 days 
postoperatively. Parameters measured were: weight, serum albumin and protein, and anastomotic bursting pressure, breaking strength and 
hydroxyproline content.
Results: Body weight was diminished significantly in rats receiving chemotherapy. Serum albumin and protein was significantly lower 
in irradiated groups. At sacrifice, 40% of I/CH  rats had functional rectal stenosis. The average bursting pressure CP=0.0005) and the 
average breaking strength (P—0.012) were only reduced significantly in the CH group, The anastomotic hydroxyproline content was 
significantly higher in the I/CH  and I/CL groups vs. the control group.
Conclusion: High-dose direct postoperative 5-FU leads to reduced anastomotic strength. Although the combination of preoperative 
irradiation (25 Gy) and direct postoperative high-dose 5-FU does not reduce early anastomotic strength, some stenosis may occur. The 
combination of preoperative irradiation and low-dose 5-FU has no such effect.
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1. Introduction
Local recurrence of colorectal cancer and metastatic 
disease after surgery are common entities; they are due to 
microscopic disease left after resection, peri-operatively 
spilled tumor cells or unrecognised metastatic disease at 
the time of operation. Over the last decades numerous 
studies have been performed, with limited success to 
determine the role of adjuvant therapy in improving the 
results of surgery. Radiotherapy and chemotherapy are 
commonly used tools for adjuvant treatment, and there 
exists increasing in combining both modalities [23].
The best interest for radiation treatment seems to be a
high-dose preoperative application [21]. The potential 
advantages for such a schedule are many. Firstly, irradia­
tion is delivered to a well vascularized tumor which is well 
oxygenized, providing a better therapeutic effect. Second­
ly, postoperative intra-abdominal adhesions, resulting in 
radiation side effects to the fixed small bowel, have not 
been formed. Thirdly, the operative wound after surgery 
would require a much larger irradiation field, giving rise to 
volume effects. Finally, implantation of tumor cells spilled 
during surgery will be less because they are less viable, 
and because the tumor is reduced in size.
Postoperative chemotherapy is believed to be effective 
in the attack on viable cancer ceils, resulting in decreased 
local recurrence, increased disease-free interval and in­
creased survival both clinically [3,25] and experimentally 
[19]. 5-Fluorouracil (5-FU) is still considered to be theCorresponding author,
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most effective single agent in the use against colonic 
cancer cells [14,16].
Separately, both types of adjuvant therapy have been 
thought to endanger the healing of bowel anastomoses 
[8,13,17,20,22,27,28]. Early disturbances of anastomotic 
healing may lead to leakage, peritonitis and death, thus 
forming a threat which might limit their use. However, the 
precise magnitude of these side-effects is still under 
investigation. Irradiation has long been considered to be 
detrimental for colon anastomotic repair [13,17,20,22], but 
recent data from others [1,12,21,29] and also from our own 
laboratory (Biert, J., Hoogenhout, J., Wobbes, T. and 
Hendriks, T\ High-dose preoperative irradiation without 
detrimental effect on early anastomotic repair in the rat 
colon. Radiat Res., in press) indicate that it can be applied 
without negative effects on early anastomotic strength or 
anastomotic integrity. With respect to chemotherapy, it has 
been shown that in the rat early bowel anastomotic repair 
is endangered by a high dose of 5-FU, given daily for 1 
week from the day of the operation onwards [8,28]. If 
treatment is limited to the first 3 days, a high dose can be 
considered safe [11,26], unless 5-FU is used together with 
other agents [27]. Lower doses of 5-FU are supposedly less 
dangerous for colon anastomotic repair.
However, the possibilities for combining two treatment 
modalities may be limited due to amplification of side- 
effects [4], So far, the possible interactions of preoperative 
irradiation and direct postoperative chemotherapy with 
respect to their effects on early anastomotic healing have 
not been investigated. Therefore, we examined the effect 
of combined preoperative irradiation with a dose of 25 Gy 
and direct postoperative 5-FU, administered in traper it one- 
ally in a high or low dose, on anastomotic healing in the 
rat colon. The effect of combined treatment was compared 
to that of either single treatment modality.
2. Materials and methods
2.1. Animals
Sixty young adult male outbred Wistar/CpbrWU rats, 
body weight 246±16 g, were used. They received water 
and standard laboratory chow (diet AM II, Hope Farms, 
Woerden, The Netherlands) ad libitum. The rats were 
randomly divided into 6 groups of 10 animals each. A part 
of the colon was (sham-)irradiated preoperatively with 25 
Gray X-rays; after 5 days, a colonic resection was per­
formed with anastomotic reconstruction. Postoperatively 
rats received 5-fluorouracil (5-FU) intraperitoneally daily, 
until sacrifice at day 7 after surgery. Rats in group C 
served as sham-treated controls (sham-irradiation plus 
postoperative saline). Groups CH and CL were sham- 
irradiated and received postoperative high- and low-dose 
chemotherapy (dose: see below), respectively. Group I was 
irradiated and received postoperative saline, while groups
I/CH and I/CL were treated by irradiation and postopera­
tive high- and low-dose chemotherapy, respectively.
This study was approved by the Animal Ethics Review 
Committee of the Faculty of Medicinal Sciences, Universi­
ty of Nijmegen.
2.2. Irradiation, dosimetiy
Before irradiation the animals were anaesthetized with 
intraperitoneal sodium pentobarbital. The irradiation pro­
cedure was based on techniques developed in a prior 
experiment (Biert, J., Hoogenhout, J., Wobbes, T. and 
Hendriks, T. High-dose preoperative irradiation without 
detrimental effect on early anastomotic repair in the rat 
colon, Radiat. Res., in press). In order to ascertain that the 
same tissue area was irradiated in each rat, and to mark 
this area for subsequent surgery, a laparotomy was per­
formed. The colonic segment to be irradiated, 1-3.2 cm 
proximal from the rectoperitoneal fold was marked by a 
serosal stitch at its proximal border. The irradiated area 
measured 2.2X0.5 cm (Fig. 1). The adjacent bowel and 
other organs were covered with a lead cone and the rest of 
the body was also shielded with lead (thickness 2.5 mm).
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Fig. 1. Schematic representation of experimental procedure. (A) First 
laparotomy plus irradiation of colonic segment. (B) Second laparotomy 
plus resection of a 1 .6-cm segment, and construction of anastomosis with 
only the distal limb consisting of irradiated tissue. (C) At sacrifice: 
sample used for hydroxyproline analysis.
J. Biert et al. I Radiotherapy and Oncology 41 (1996) 257-262 259
Radiation dosimetry was performed by means of ther­
moluminescent dosimeters and film densitometry in sepa­
rate animals. Irradiation was performed with a 250 kV 
X-ray unit with a 1 mm Cu filter (target/colon distance: 25 
cm). The dose rate was 1.29 Gy/min. Thus, all rats in 
groups I/CH, I/CL and I received a dose of 25 Gy.
23. Operative procedure, chemotherapy
After 5 days animals were anaesthetized again with 
intraperitoneal sodium pentobarbital. The median 
laparotomy wound was opened and a 1.6-cm colonic 
segment was resected. This segment was identified by the 
marking stitch left during the initial laparotomy and 
measured 0.5 cm in proximal and 1.1 cm in distal direction 
(Fig. 1). Thus, the proximal limb to be used for the 
anastomosis consisted of non-irradiated tissue, while the 
first LI cm of the distal limb had been irradiated (groups 
I/CH, I/CL and I). Continuity was restored by an invert­
ing one-layer end-to-end anastomosis with eight inter­
rupted monofilament sutures (Ethilon 8X0, Ethicon, Nor- 
derstedt, Germany) using microsurgical techniques. Fascia 
and skin were closed with a catgut running suture and 
staples, respectively.
Chemotherapy was started immediately after operation, 
and the intraperitoneal way of administration was chosen 
on the basis of earlier work of our group [26,28]: 5-FU, 
administered intraperitoneally from the day of operation 
onwards in a daily dose of 20 m g/kg body weight —  
which is the maximum tolerated dose —  strongly reduced 
strength and accumulation of collagen in 7 days old 
intestinal anastomoses in the rat [28]. Based on these 
findings, groups I/CH and CH (high-dose groups) now 
received 17.5 mg 5-FU/kg body weight intraperitonally in 
saline in a single dose every day until sacrifice. Groups 
I/CL and CL (low-dose groups) received 12.5 mg FU/kg 
body weight daily, while in groups I and C the same 
volume of saline was given every day as in group I/CH  
(sham medication treatment).
2,4. Analytical procedures
The condition of the animals was monitored and weight 
was measured daily. Seven days after the operation the rats 
were killed by cardiac puncture. A blood sample was taken 
for albumin and protein measurement to monitor general 
nutritional condition. The abdomen was inspected for 
adhesions, rectal stenosis, abscesses or other abnormalities. 
The anastomoses were resected en bloc. Healing was 
assessed by measurement of anastomotic strength and 
hydroxyproline content [10]. In order to determine anas­
tomotic strength, the anastomotic segment was washed in 
saline and connected to an infusion pump on one side 
while the other side was clamped. A manometer was 
connected by a side line. The bursting pressure was 
measured by raising the intraluminal pressure by infusion
of a methylene blue/saline solution at a rate of 2  ml/min. 
The procedure was performed in water for better visualisa­
tion of the bursting site. The bursting pressure was defined 
as the maximal intraluminal pressure the segment resisted, 
expressed in mmHg. The bursting site was noted. The 
breaking strength of the segment, as a measure of the 
resistance to longitudinal forces, was measured immedi­
ately after determination of the bursting pressure [27], The 
segment was placed in a tensiometer that provided a 
constantly increasing distraction, The peak force (in g) 
necessary to induce total disruption of the segment was 
taken as the breaking strength. The breaking site was 
noted. After this, adhesions and fat tissue were removed 
from the segment and a 0,5 cm sample containing both 
sides of the suture line was collected (Fig. 1) and stored in 
liquid nitrogen for hydroxyproline assay.
Anastomotic samples, and control segments removed at 
operation, were weighed, lyophilized, and pulverized. The 
hydroxyproline content, as a measure for collagen, was 
measured by HPLC after hydrolysis with 6 N HC1 and 
deiivatisation with dabsylchloride.
Differences between the control group and the five 
experimental groups were tested for significance using a 
two-tailed Mann-Whitney test. To correct for the fact that 
multiple comparisons were made, pairwise comparisons 
were done using a level of significance of a ' —2 a /k ,  where 
k is the total number of pairwise comparisons. Thus, 
differences between groups were considered significant 
(a =0.05) at P < a \  where a ' ==0.02.
3. Results
3.1, General observations
All animals tolerated chemotherapeutic treatment and/or 
radiotherapy well. Moderate to severe diarrhea was appar­
ent in all but the C groups. One animal in the I/CH group 
died on the sixth postoperative day —  obduction revealed 
no abnormalities. One rat in group CL was moribund at the 
time of sacrifice. Functional rectal stenosis was defined as 
a 2-times or more enlarged proximal anastomotic limb 
diameter with faecal impaction, although passage of stool 
was still possible; this condition was seen in 4 rats in 
group I/CH and in 1 rat in group I/CL.
Anastomotic abscesses were seen once in groups I/CH, 
I/CL and CH each.
3.2. Body weight
After the first anaesthesia, all rats lost some weight: 
recovery seemed slower in the irradiated groups (Fig. 2). 
The second anaesthesia again resulted in weight loss, 
which was similar in all groups on the first postoperative 
day. Thereafter, all rats under 5-FU medication lost 
progressively more weight; the high dose groups most.
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Fig. 2. Body weight as a function of time after (sham-)irradiation. (□ )  C 
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Fig. 3. Anastomotic bursting pressure. Each point represents a measure­
ment in one single animal. (O) Bursting site within the anastomosis; ( • )  
bursting site outside the anastomosis. Statistically significant differences 
are shown (Mann-Whitney test). * P = 0.0005.
Rats treated with sham-medication gained weight again. In 
comparison with the control group differences were signifi­
cant in the I/CL group from day 7 onwards, in groups CH 
and I/CH from day 8 onwards and in the CL group from 
day 11 onwards. The I group showed no significant 
differences with the control group.
3.3. Serum  album in  an d  p r o te in
Serum albumin and protein measurements are depicted 
in Table 1. At sacrifice there were significant differences 
between all irradiated groups and the control group (except 
for albumin in the I group); this difference appeared 
progressively more pronounced in groups I/CL and I/CH. 
The CH group also showed lower values for serum protein.
3.4. A n a s to m o tic  healing
Individual bursting pressure measurements and bursting 
sites are depicted in Fig. 3, Seven days after operation the 
bursting site was almost invariably outside the suture line 
in both the C and I groups. Treatment with 5-FU led to 
weakening of the anastomotic bursting pressure, as indi-
Table 1
Serum albumin and protein at sacrifice
Group Serum albumin Serum protein
C 24 ± 2 .8 55± 4 .2
CL 2 5 ±  1.7 55±3.8
CH 23 ± 1 .4 50±3.1*
I 22±1.2* 51 ±2.4*
I/C L 21 ±1.0* 50±2.7*
I/C H 20±2.2* 47 ±3.2*
Data are given as m ean±S .D M and are expressed in g/1.
Differences between experimental groups and the control (C) group were 
tested for significance using a Mann-Whitney test; *P<0.02 .
cated by a shift in bursting site to the anastomotic area and 
reduced mean values in CL and CH (P = 0.0005; Mann- 
Whitney) groups. Groups which had received the radiation 
dose all showed higher average bursting pressures than 
their sham-irradiated counterparts.
Breaking strength measurements are depicted in Table 2. 
Mean values were higher in the I group as compared to the 
control group, and lower in all other groups. Statistical 
significance was reached in the CH group only (P=0.012; 
Mann-Whitney). The site of the anastomotic rupture was 
always located inside the anastomosis, except for 1 rat in 
the I/CL group and 3 rats in the I group.
Hydroxyproline concentration and content of anas­
tomotic samples are depicted in Table 2. There were no 
significant differences in hydroxyproline concentration 
between experimental groups and the control group. The 
mean hydroxyproline content was increased in all but the 
CL groups. The difference with the control group reached 
statistical significance in the I/CH  group (P = 0.0003) and 
the I/CL group (P=0.0015).
4. Discussion
In this study it is shown that high dose preoperative 
irradiation combined with a low dose of intraperitoneal 
5-FU, applied in the immediate postoperative period, does 
not influence early strength o f experimental colonic anas­
tomoses. Although there were no statistical differences 
concerning anastomotic strength, reservations must be 
made for the application of a combination of preoperative 
irradiation with high dose 5-FU. Animals in the I/CH  
group lost much weight (during the experiment almost 
20%). This went together with a significantly decreased 
serum albumin and protein (P = 0.0003 and P<0,0001, 
respectively). The high incidence of functional rectal
Table 2
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Breaking strength, hydroxy proline concentration, and hydroxyproline content of anastomotic segments
Group Breaking strength Hydroxyproline concentration Hydroxyproline content
C 217±62 16.4±1.7 331+51
CL 182 ±54 15.2+1.8 305 ±75
CH 156+41** 18.3+3.5 403 ± 168
1 254±41 18.3+2 421 ±96
I/CL 177 ±65 18.8+4.3 497±120*
I/CH 175 ±47 14.8 ±2.9 498±82*
Data are given as average values±S.D., and are expressed in g (breaking strength), jxg hydroxyproline/5 mm anastomotic segment (HP concentration), or 
fig hydroxyproline/mg dry weight (HP content).
Differences between experimental groups and the control (C) group were tested for significance using a Mann-Whitney test; **P=0.012, *F^0.0015.
stenosis (4 out of 9), with another animal dying for 
unknown reasons before the end of the experiment, raises 
doubts about the safety of this combination. The increased 
anastomotic hydroxyproline (collagen) content in the I/CH  
and I/CL groups suggests a strong fibrotic reaction, even 
stronger than the reaction seen after irradiation alone. This 
fibrosis does not lead to increased early strength as 
compared to the control group. However, the possibility 
cannot be excluded that it might be the start of future rectal 
stenosis.
Clinical and experimental trials concerning surgery for 
colorectal cancer are increasingly focused on the applica­
tion of adjuvant therapies [23]. Some clinical studies have 
dealt with combined effects of radiotherapy and chemo­
therapy as an adjunct to surgery, although so far a 
combination of preoperative irradiation and direct post­
operative chemotherapy has not been reported yet. Graf 
describes undisturbed anastomotic wound healing after a 
7-day course of 5-FU plus leucovorin intraperitonally [9].
In a prospective study by Chari, in a group of 43 
patients, a combination of 5-fiuorouracil, cisplatin and 
preoperative irradiation with a dose of 45 Gy in fractions 
was given in a 5-week period prior to resection; this 
resulted in increased survival, decreased local recurrence 
and increased disease-free interval [3]. Only five patients 
underwent a low anterior resection with anastomotic 
construction. No anastomotic leakage occurred in these 
patients.
The beneficial effects of the combination of postopera­
tive irradiation with prolonged postoperative chemotherapy 
on survival and tumor recurrence, especially in patients 
stage Dukes B or C rectal carcinoma, has also been proven 
in two prospective randomized trials [5,15]. However, 
nowadays adjuvant radiation therapy is generally thought 
to be most effective in the preoperative setting [7,18,21].
Adjuvant intraperitoneal chemotherapy is most useful in 
the first days after surgery. Since hardly any adhesions 
have been formed the anastomotic site and surrounding 
pelvic wall have not yet been sealed off, allowing a wide 
spread of the drug at the right location [24]. Also, high 
doses of regional chemotherapy over prolonged (120 h) 
time periods should translate into a high fraction of cell
kill and a small likelihood of drug resistance [24]. Further­
more, 5-FU administered intraperitoneally is preferably 
taken up by the visceral peritoneum, resulting in a high 
concentration in portal venous blood, in this way working 
possibly more powerful against hepatic implantation of 
metastatic cells than systemic application [19,24].
The combination of radiotherapy and chemotherapy is 
being used more and more often to improve results of 
adjunct therapy to surgery for cancer, as is done in 
colorectal cancer patients. Application can be sequentially, 
alternated or simultaneously [2]. When a sequential order 
is followed, and 5-FU is administered first, synchronisation 
and radiosensitation occur. If radiotherapy is given first, 
more cells become sensitive to 5-FU [2]. In cancer cell 
lines the effect was more pronounced if irradiation pre­
ceded 5-FU [2]. In mice, the same experiment showed that 
chronology of both adjunct therapy modalities was not 
important, although simultaneous application gave slightly 
better results [6].
In the present experiment we used maximally 17.5 mg
5-FU/kg body weight, aiming at the highest dose which 
would leave colonic repair essentially unaffected [28], 
Still, this regimen (the CH group) significantly reduced 
anastomotic strength, although without concomitant de­
crease in wound hydroxyproline content. The lower dose 
of 12.5 mg 5-FU/kg body weight (the CL group) did not 
significantly reduce wound strength, although the mean 
values of the strength measurements were lower than in the 
control group. This effect of 5-FU was independent of 
prior irradiation treatment: the decline in strength from C 
to CL and CH groups (Fig. 3, Table 2) was similar to that 
from I to I/CL and I/CH groups. Thus the detrimental 
effect of 5-FU was not enhanced by preoperative irradia­
tion.
In conclusion, our data show that the combination of 
preoperative irradiation and direct postoperative chemo­
therapy does not lead to detrimental effects on anastomotic 
strength, although (high-dose) chemotherapy alone sig­
nificantly reduces anastomotic strength. However, the 
combined use of preoperative irradiation with high-dose 
postoperative 5-FU seems questionable because of in­
creased frequency of rectal stenosis.
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